Menu
GeneBe

DCHS1

dachsous cadherin-related 1, the group of Cadherin related

Basic information

Region (hg38): 11:6621329-6655809

Previous symbols: [ "CDH25", "PCDH16" ]

Links

ENSG00000166341NCBI:8642OMIM:603057HGNC:13681Uniprot:Q96JQ0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • van Maldergem syndrome 1 (Strong), mode of inheritance: AR
  • familial mitral valve prolapse (Supportive), mode of inheritance: AD
  • van Maldergem syndrome (Supportive), mode of inheritance: AR
  • mitral valve prolapse, myxomatous 2 (Strong), mode of inheritance: AD
  • van Maldergem syndrome 1 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Mitral valve prolapse 2; Van Maldegrem syndrome 1AD/ARAudiologic/Otolaryngologic; CardiovascularFor Mitral valve prolapse, individuals may manifest with severe mitral valve prolapse leading to heart failure and requiring surgery, and awareness may allow prompt diagnosis and management; For Van Maldegrem syndrome, early recognition and treatment of hearing impairment may improve outcomes, including speech and language developmentAudiologic/Otolaryngologic; Cardiovascular; Craniofacial; Musculoskeletal; Neurologic; Renal12707861; 24056717; 26258302

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the DCHS1 gene.

  • not provided (1172 variants)
  • Inborn genetic diseases (166 variants)
  • not specified (33 variants)
  • Van Maldergem syndrome 1 (28 variants)
  • Mitral valve prolapse, myxomatous 2 (13 variants)
  • DCHS1-related condition (13 variants)
  • Lymphedema (4 variants)
  • 11 conditions (3 variants)
  • Van Maldergem syndrome 1;Mitral valve prolapse, myxomatous 2 (3 variants)
  • DCHS1-related disorder (2 variants)
  • Cardiomyopathy (1 variants)
  • Mitral valve prolapse, myxomatous 2;Van Maldergem syndrome 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the DCHS1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
12
clinvar
304
clinvar
28
clinvar
344
missense
1
clinvar
682
clinvar
54
clinvar
17
clinvar
754
nonsense
7
clinvar
2
clinvar
4
clinvar
13
start loss
0
frameshift
4
clinvar
1
clinvar
4
clinvar
9
inframe indel
5
clinvar
1
clinvar
1
clinvar
7
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
12
14
4
30
non coding
3
clinvar
46
clinvar
23
clinvar
72
Total 12 4 710 405 69

Highest pathogenic variant AF is 0.0000329

Variants in DCHS1

This is a list of pathogenic ClinVar variants found in the DCHS1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-6621526-TGAG-T Likely benign (Oct 09, 2018)1203506
11-6621604-C-T Likely benign (Apr 14, 2019)1194107
11-6621791-C-G Uncertain significance (Dec 10, 2022)2878734
11-6621793-C-G Inborn genetic diseases Uncertain significance (Nov 10, 2021)1463397
11-6621794-C-T DCHS1-related disorder Likely benign (May 19, 2023)1923330
11-6621795-G-A Uncertain significance (Dec 07, 2023)1991233
11-6621797-G-A Likely benign (Nov 15, 2023)1595475
11-6621806-T-C Likely benign (May 30, 2023)1644481
11-6621810-T-A Uncertain significance (Dec 09, 2023)2966029
11-6621817-C-A Uncertain significance (Jan 09, 2024)1909767
11-6621826-C-T Likely benign (Mar 13, 2023)1631699
11-6621827-G-A Likely benign (Nov 19, 2023)2641557
11-6621832-G-C Inborn genetic diseases Uncertain significance (Feb 15, 2023)2484050
11-6621835-C-A Uncertain significance (Dec 11, 2021)2039984
11-6621837-G-A Uncertain significance (Mar 10, 2023)2870710
11-6621842-T-C Likely benign (Jan 06, 2024)770971
11-6621852-T-C Uncertain significance (Nov 02, 2023)1518872
11-6621872-G-A Likely benign (Feb 02, 2022)2419623
11-6621877-C-T Uncertain significance (Jan 19, 2024)1507671
11-6621878-G-A Likely benign (Sep 12, 2022)1589221
11-6621879-G-A Conflicting classifications of pathogenicity (Jan 21, 2024)764789
11-6621882-G-A Uncertain significance (Oct 12, 2020)1313304
11-6621885-C-T Inborn genetic diseases Uncertain significance (Dec 19, 2023)1980445
11-6621886-G-A Inborn genetic diseases Uncertain significance (Jul 03, 2023)2192581
11-6621889-C-T Inborn genetic diseases Uncertain significance (Aug 28, 2023)1932552

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
DCHS1protein_codingprotein_codingENST00000299441 2034530
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.000.00002901255630301255930.000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.4016301.93e+30.8460.00012520449
Missense in Polyphen571776.790.735078914
Synonymous1.507568100.9330.00005057695
Loss of Function7.641595.60.1570.00000637978

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002100.000210
Ashkenazi Jewish0.0002990.000298
East Asian0.00006480.0000544
Finnish0.0002390.000231
European (Non-Finnish)0.0001110.000106
Middle Eastern0.00006480.0000544
South Asian0.0001520.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Calcium-dependent cell-adhesion protein. Mediates functions in neuroprogenitor cell proliferation and differentiation. In the heart, has a critical role for proper morphogenesis of the mitral valve, acting in the regulation of cell migration involved in valve formation (PubMed:26258302). {ECO:0000269|PubMed:26258302}.;
Disease
DISEASE: Mitral valve prolapse 2 (MVP2) [MIM:607829]: A form of mitral valve prolapse, a valvular hearth disease characterized by abnormally elongated and thickened mitral valve leaflets, that typically show myxomatous degeneration with increased leaflet compliance. It is associated with mitral regurgitation. Myxomatous mitral valves have an abnormal layered architecture characterized by loose collagen in fibrosa, expanded spongiosa strongly positive for proteoglycans, and disrupted elastin in atrialis. In classic mitral valve prolapse, leaflets are at least 5 mm thick, whereas in the non-classic form, they are less than 5 mm thick. Severe classic mitral valve prolapse is strongly associated with arrhythmias, endocarditis, heart failure, and need for valve surgery. {ECO:0000269|PubMed:26258302}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Hippo signaling pathway - multiple species - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.131

Intolerance Scores

loftool
0.261
rvis_EVS
-1.38
rvis_percentile_EVS
4.4

Haploinsufficiency Scores

pHI
0.330
hipred
Y
hipred_score
0.623
ghis
0.529

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.580

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Dchs1
Phenotype
growth/size/body region phenotype; respiratory system phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
dchs1b
Affected structure
fertilized egg
Phenotype tag
abnormal
Phenotype quality
disoriented

Gene ontology

Biological process
branching involved in ureteric bud morphogenesis;mitral valve formation;cell migration involved in endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;pattern specification process;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;neural tube development;neurogenesis;hippo signaling;post-anal tail morphogenesis;ossification involved in bone maturation;digestive tract development;condensed mesenchymal cell proliferation;protein localization to plasma membrane;cochlea development
Cellular component
plasma membrane;membrane;integral component of membrane;apical part of cell
Molecular function
calcium ion binding